It is known that the c-KIT receptor (CD117+) is highly expressed in normal epithelium of the breast and progressively decreases with the development of breast carcinoma in situ and is almost completely lost in invasive breast cancer [42, 43]. This evidence concerns the gene KIT and breast carcinoma in situ.